JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katada, J.
Right arrow Articles by Majima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katada, J.
Right arrow Articles by Majima, M.

Vol. 302, Issue 3, 949-956, September 2002

Significance of Vascular Endothelial Cell Growth Factor Up-Regulation Mediated via a Chymase-Angiotensin-Dependent Pathway during Angiogenesis in Hamster Sponge Granulomas

Jun Katada, Michiko Muramatsu , Izumi Hayashi, Masahiro Tsutsumi, Yoichi Konishi and Masataka Majima

Department of Pharmacology, Kitasato University School of Medicine, Kanagawa, Japan (J.K., I.H., M.M.); Department of Pharmacology, Osaka Medical College, Osaka, Japan (M.M.); and Department of Oncological Pathology, Cancer Center, Nara Medical University, Nara, Japan (M.T., M.M.)

Chymase is a serine protease responsible for local production of angiotensin (Ang) II from its precursor Ang I in several species, including humans, dogs, and hamsters. We have previously reported that chymase facilitates angiogenesis in sponge granulation tissues via local production of Ang II. Herein, we report the significance of vascular endothelial growth factor (VEGF) up-regulation mediated by Ang II during angiogenesis in hamster sponge granulomas. Treatment of granulation tissues with an anti-VEGF neutralizing antibody or antisense oligomers against VEGF mRNA significantly reduced Ang II-induced angiogenesis, supporting a significant role for VEGF during angiogenesis. In cultured fibroblasts prepared from granulation tissues, VEGF mRNA was up-regulated in response to Ang II within 2 h and this enhanced expression was abolished in the presence of an Ang II type 1 receptor-selective antagonist, an inhibitor of nuclear factor-kappa B activation, or an activator protein-1 inhibitor. To study the significance of local production of Ang II by chymase, we examined the effects of chymostatin on in vivo angiogenesis. We found that chymostatin markedly inhibited both up-regulation of VEGF mRNA and angiogenesis in granulation tissues treated by compound 48/80 or basic fibroblast growth factor. Our results suggest that Ang II directly acts on fibroblasts in granulation tissue to up-regulate VEGF mRNA and thereby induce angiogenesis. Furthermore, a chymase-Ang II-VEGF pathway may operate in granulation tissue as the primary mediator of angiogenesis.

0022-3565/02/3023-0949$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Immunol.Home page
W. W. Raymond, S. Su, A. Makarova, T. M. Wilson, M. C. Carter, D. D. Metcalfe, and G. H. Caughey
{alpha}2-Macroglobulin Capture Allows Detection of Mast Cell Chymase in Serum and Creates a Reservoir of Angiotensin II-Generating Activity
J. Immunol., May 1, 2009; 182(9): 5770 - 5777.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. M. Phillips and J. I. Goodman
Identification of Genes that May Play Critical Roles in Phenobarbital (PB)-Induced Liver Tumorigenesis due to Altered DNA Methylation
Toxicol. Sci., July 1, 2008; 104(1): 86 - 99.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. W. Mastaitis, E. Wurmbach, H. Cheng, S. C. Sealfon, and C. V. Mobbs
Acute Induction of Gene Expression in Brain and Liver by Insulin-Induced Hypoglycemia
Diabetes, April 1, 2005; 54(4): 952 - 958.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Fujita, I. Hayashi, S. Yamashina, A. Fukamizu, M. Itoman, and M. Majima
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth
Carcinogenesis, February 1, 2005; 26(2): 271 - 279.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Ikeda, I. Hayashi, E. Kamoshita, A. Yamazaki, H. Endo, K. Ishihara, S. Yamashina, Y. Tsutsumi, H. Matsubara, and M. Majima
Host Stromal Bradykinin B2 Receptor Signaling Facilitates Tumor-Associated Angiogenesis and Tumor Growth
Cancer Res., August 1, 2004; 64(15): 5178 - 5185.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. A Doggrell and J. C Wanstall
Vascular chymase: pathophysiological role and therapeutic potential of inhibition
Cardiovasc Res, March 1, 2004; 61(4): 653 - 662.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. Ritz
Chymase: A Potential Culprit in Diabetic Nephropathy?
J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1952 - 1954.
[Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.